Literature DB >> 26396990

Chronic norovirus infection in a patient with a past history of Burkitt lymphoma.

Leesa D Bruggink1, Lachlan Hayes2, John A Marshall1.   

Abstract

The noroviruses are a leading cause of gastroenteritis worldwide. Although the illness is normally mild and self-limiting, there is a growing literature documenting the chronic excretion of norovirus in the immunocompromised. The aim of the current study was to examine the molecular features of chronic norovirus excretion in an immunocompromised patient with a past history of Burkitt lymphoma. During the 241 day course of the study from December 2013 to August 2014, seven faecal specimens were collected from the patient, tested for norovirus by RT-PCR and further analysed in the open reading frame (ORF) 1 and ORF 2 regions. All seven specimens were positive for norovirus by RT-PCR. Molecular sequencing in the polymerase (ORF 1) and capsid (ORF 2) regions indicated that the norovirus could be classified as GII.4 (2006b)/GII.4 (unknown). No significant mutation was found in the ORF 1 or ORF 2 regions analysed over the period of the study. The current report appears to be the first to document chronic norovirus excretion in a patient with a past history of Burkitt lymphoma. It is also the first to indicate long term norovirus excretion in a given individual need not involve major genetic change in key regions of the genome.

Entities:  

Keywords:  Burkitt lymphoma; Chronic excretion; Immunocompromised; Norovirus

Year:  2015        PMID: 26396990      PMCID: PMC4571591          DOI: 10.1007/s13337-015-0275-7

Source DB:  PubMed          Journal:  Virusdisease        ISSN: 2347-3584


  14 in total

1.  Norovirus GII.4 and GII.7 capsid sequences undergo positive selection in chronically infected patients.

Authors:  Dieter Hoffmann; Martin Hutzenthaler; Judith Seebach; Marcus Panning; Andreas Umgelter; Helge Menzel; Ulrike Protzer; Dirk Metzler
Journal:  Infect Genet Evol       Date:  2012-01-30       Impact factor: 3.342

2.  Molecular and epidemiological features of GIIb norovirus outbreaks in Victoria, Australia, 2002-2005.

Authors:  L D Bruggink; J A Marshall
Journal:  J Med Virol       Date:  2009-09       Impact factor: 2.327

3.  Elimination of norovirus in a chronic carrier under immunosuppression after heart transplantation--effect of everolimus.

Authors:  Markus A Engelen; Stefan Gunia; Joerg Stypmann
Journal:  Transpl Int       Date:  2011-08-31       Impact factor: 3.782

4.  Norovirus infection in immunocompromised children and children with hospital-acquired acute gastroenteritis.

Authors:  Naeemah Munir; Pengbo Liu; Paul Gastañaduy; Julia Montes; Andi Shane; Christine Moe
Journal:  J Med Virol       Date:  2013-09-30       Impact factor: 2.327

5.  Emergence of GII.e as a major ORF 1 norovirus genotype and its associated ORF 2 GII.4 variant forms.

Authors:  L D Bruggink; N L Dunbar; J A Marshall
Journal:  Infect Genet Evol       Date:  2014-01-28       Impact factor: 3.342

6.  Systematic analysis of viral genes responsible for differential virulence between American and Australian West Nile virus strains.

Authors:  Yin Xiang Setoh; Natalie A Prow; Daniel J Rawle; Cindy Si En Tan; Judith H Edmonds; Roy A Hall; Alexander A Khromykh
Journal:  J Gen Virol       Date:  2015-01-27       Impact factor: 3.891

Review 7.  Norovirus infection in immunocompromised hosts.

Authors:  K Y Green
Journal:  Clin Microbiol Infect       Date:  2014-08       Impact factor: 8.067

8.  Quasispecies dynamics and molecular evolution of human norovirus capsid P region during chronic infection.

Authors:  Beatrice Carlsson; A Michael Lindberg; Jesús Rodriguez-Díaz; Kjell-Olof Hedlund; Bengt Persson; Lennart Svensson
Journal:  J Gen Virol       Date:  2009-02       Impact factor: 3.891

9.  Proposal for a unified norovirus nomenclature and genotyping.

Authors:  Annelies Kroneman; Everardo Vega; Harry Vennema; Jan Vinjé; Peter A White; Grant Hansman; Kim Green; Vito Martella; Kazuhiko Katayama; Marion Koopmans
Journal:  Arch Virol       Date:  2013-04-25       Impact factor: 2.574

10.  Norovirus-related chronic diarrhea in a patient treated with alemtuzumab for chronic lymphocytic leukemia.

Authors:  Anne-Marie Ronchetti; Benoit Henry; Katia Ambert-Balay; Pierre Pothier; Justine Decroocq; Véronique Leblond; Damien Roos-Weil
Journal:  BMC Infect Dis       Date:  2014-05-06       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.